DLL3/Notch binding prevents dislocation of the receptor on the cell surface and emerges on the cell membrane when it is pathologically overexpressed, resulting in aberrant growth of neuroendocrine tumor cells, including SCLC and large-cell neuroendocrine carcinoma (LCNEC) (13, 16). Here, DLL3 is linked to small cell lung carcinoma.